During mammalian spermatogenic differentiation, more than half of the differentiating spermatogenic cells die, probably by apoptosis, before they mature into spermatozoa (for review, see Refs. [1] [2] [3] [4] [5] [6] , although the mechanism and functional significance of this phenomenon are unknown. The occurrence of spermatogenic cell apoptosis at various stages of differentiation has been reported (6 -11) . Only a limited number of apoptotic spermatogenic cells, however, are detectable when testis sections are histochemically examined. This is probably due to the rapid elimination of apoptotic cells by phagocytosis. In fact, electron microscopic studies with rodent testis sections reveal that degenerating spermatogenic cells are engulfed by Sertoli cells (12) (13) (14) (15) (16) . We previously showed that rat Sertoli cells in primary cultures phagocytose apoptotic spermatogenic cells in a manner dependent on the membrane phospholipid phosphatidylserine (PS) 1 exposed on the surface of the apoptotic cells and class B scavenger receptor type I (SR-BI) present in Sertoli cells (17) (18) (19) .
Cells undergoing apoptosis are selectively and rapidly eliminated from the organism by phagocytosis (for review, see Refs. 20 and 21) . This process contributes not only to the clearance of unnecessary or spent cells from the body but also maintaining tissue homeostasis (for review, see Refs. 22 and 23); for example, removal of possible autoantigens (for review, see Refs. 24 and 25) and pro-inflammatory substances in dying cells, removal of microbe-infected cells (26) , inhibition of inflammation by altering secretion of cytokines from macrophages (for review, see Ref. 27) , control of the immune response (for review, see Ref. 28) , and control of gamete production (29) . It is, thus, of great importance to elucidate the mechanism underlying phagocytosis of apoptotic cells, which presumably consists of various distinct events such as the migration of phagocytes toward the site of apoptosis, the recognition and engulfment of apoptotic cells by phagocytes, processing of engulfed apoptotic cells in phagocytes, and the alteration of gene expression in engulfing phagocytes. Although investigation of these phenomena (especially the recognition step) has recently become intensive, most mechanisms still remain unclear.
Phagocytes such as macrophages bind to apoptotic cells, probably by recognizing phagocytosis marker molecules that are expressed on the surface of target cells (for review, see Refs. 23 and 30) ; the membrane phospholipid PS is the best-characterized phagocytosis marker (for review, see Refs. [31] [32] [33] [34] . PS, which is normally restricted to the inner leaflet of the membrane bilayer, translocates to the outer leaflet and is exposed to the cell surface during apoptosis (for review, see Refs. 35 and 36) by a caspase-mediated mechanism of which the details remain unknown (for review, see Refs. 31 and 34) . Exposure of PS at the surface of apoptotic cells is easily examined by flow cytometry using fluorescence-labeled annexin V, which specifically binds to PS (37, 38) , and this property has been utilized to locate PS-exposing cells in vivo (39 -43) . Externalized PS serves as a "phagocytosis marker"; that is, phagocytes recog-nize apoptotic cells by using PS receptors and engulf those cells. We recently showed the occurrence of PS-mediated phagocytosis in vivo; microinjection of annexin V into the seminiferous tubules of live mice inhibited phagocytosis of apoptotic spermatogenic cells by Sertoli cells (29) . Not only phagocytes that are circulating throughout the body but also tissue-restricted phagocytic cells, sometimes called amateur phagocytes, perform PS-mediated phagocytosis of apoptotic cells; these include microglial cells in the brain, endothelial cells in the blood vessels, and Sertoli cells in the testis. These phagocytes seem to possess distinct PS receptors (34) , among which lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) of endothelial cells (44) , SR-BI of Sertoli cells (19) , and the macrophage PS receptor (45) have so far been reported. The mode of function of those molecules as phagocytosis-inducing PS receptors is mostly unknown, and it has even remained unclear whether or not they directly bind to PS. One exception, the product of growth arrest-specific gene 6 (Gas6), has been shown to specifically bind to PS in a cell-free system (46) and stimulate macrophage phagocytosis of apoptotic cells (47) . However, Gas6, a non-membrane-anchored protein, is likely to be a kind of adapter and need another membrane protein to transmit the phagocytosis-inducing signal to phagocytes (the Axl/Mer/Tyro3 receptor-tyrosine kinase family of proteins are candidates for such receptors) (47) (48) (49) .
SR-BI, a member of the scavenger receptor family, has two transmembrane domains and is localized to the caveolae (for review, see Ref. 50) . SR-BI is a multiligand receptor whose ligands include relatively simple molecules such as anionic phospholipids and cholesterol esters, more complex molecules such as high density lipoprotein, acetylated or oxidized low density lipoprotein and negatively charged liposomes, and apoptotic cells (for review, see Refs. 51 and 52). In the present study, we evaluated the SR-BI activity of binding to PS using a cell-free solid-phase assay.
EXPERIMENTAL PROCEDURES
Cells-Dispersed testicular cells were prepared from the testes of 20-day-old Donryu rats as described previously (18, 53) . Briefly, seminiferous tubules were released from testes by collagenase treatment, and cells in the tubules were dispersed with trypsin. The dispersed cells were seeded on collagen-coated dishes containing F12-L15 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1 g/ml norepinephrine and incubated at 32.5°C with 5% CO 2 in air. Under these conditions, Sertoli cells formed monolayers on the collagen bed, and spermatogenic cells survived being lightly attached to the Sertoli cells. After 3 days, spermatogenic cells were recovered with a purity of greater than 80% (18) . Human leukemic Jurkat cells were maintained in RPMI 1640 medium containing 10% FBS at 37°C with 5% CO 2 in air. The Chinese hamster ovary (CHO) cell line K1 was cultured in F12 medium containing 10% FBS at 37°C with 5% CO 2 in air. 293T cells, a human embryonic kidney cell line expressing the adenovirus E1 region and SV40 T antigen, were maintained in Dulbecco's modified minimal essential medium containing 10% heat-inactivated FBS at 37°C with 5% CO 2 in air.
Apoptosis Induction-Isolated spermatogenic cells were cultured for 2 days to induce spontaneous apoptosis as previously described (18) . Jurkat cells were induced to undergo apoptosis by incubation with doxorubicin (0.3 g/ml) for 24 -31 h as described previously (54) . The extent of apoptosis in both types of cell was monitored by determining chromatin condensation and PS externalization as described previously (18, 54) .
Establishment of SR-BI-expressing CHO Cell Lines-The entire coding region of rat SR-BI cDNA (19, 56) was inserted into the expression vector pRC/CMV (Invitrogen) and introduced into CHO-K1 cells by the calcium/phosphate method using standard procedures. Isolated colonies that grew in the presence of G418 (Promega, Madison, WI) were picked and analyzed for the expression of SR-BI by Western blotting with an anti-hamster SR-BI antiserum. Three independent clones that expressed SR-BI at almost the same level were selected and used in the study.
Cell Adhesion Assay-Rat spermatogenic cells and Jurkat cells were induced to undergo apoptosis as described above. Cell populations (1 ϫ 10 6 cells), which were mostly apoptotic but retained plasma membrane integrity, were surface-labeled with biotin (NHS-LC-Biotin, Pierce) and added to rat SR-BI-expressing CHO-K1 cells (4 ϫ 10 5 ). The mixture was incubated at 37°C for 2 h, washed, fixed, and permeabilized as described previously (18, 54) . The samples were then supplemented with fluorescein isothiocyanate (FITC)-labeled avidin (FITC-avidin D; Vector, Burlingame, CA) and examined under a fluorescence and phasecontrast microscope. The number of SR-BI-expressing cells with fluorescent cells either attached or incorporated was determined and expressed relative to the total number of SR-BI-expressing cells (in percentage). The mean and S.D. of a typical example from at least two independent experiments that yielded similar results are presented.
Liposome Preparation and Liposome Incorporation Assay-Liposomes were formed using either phosphatidylcholine (PC) only (PC liposomes) or a combination of PC and PS at a molar ratio of 7:3 (PS liposomes) as described previously (18) . Fluorescence-labeled liposomes were prepared with N-(lissamine rhodamine B sulfonyl)-L-␣-phosphatidylethanolamine (Avanti Polar Lipids, Alabaster, AL) as 1% of total phospholipids. SR-BI-expressing CHO-K1 cells were incubated with fluorescence-labeled PS liposomes at 37°C for 1 h, washed, and examined by flow cytometry for incorporation of the liposomes as described previously (18) .
Preparation of Recombinant Rat SR-BI Fused with Human Fc-A portion of rat SR-BI cDNA corresponding to the entire extracellular domain (SRBIecd) was inserted into the vector pEF-BOS-V␣Ј-Fc so that the SR-BI sequence was fused with the human T cell receptor-derived signal peptide at the amino terminus and with the human IgG Fc region at the carboxyl terminus, and this DNA was introduced into 293T cells by the calcium/phosphate method. DNA fragments corresponding to various portions of SRBIecd were synthesized by PCR and expressed in 293T cells as above. The transfectants were cultured in the presence of 10% FBS (ultra-low IgG FBS; Invitrogen), and culture media were collected after 4 days. SR-BI proteins fused with Fc were purified using protein A-Sepharose (Amersham Biosciences). The extracellular domain of human Axl (48) was similarly prepared as an Fc fusion protein (Axlecd-Fc) and used in the PS binding assay as a negative control.
PS Binding Assay-For the solid-phase assay, phospholipids diluted with ethanol were added to 96-well plastic plates (MS-8496F; Sumitomo Bakelite, Tokyo, Japan) (0.3 g/well) and left to dry at room temperature. Recombinant Fc fusion proteins were added to the wells that had been treated with Tris-buffered saline (20 mM Tris-HCl (pH 7.5), 0.15 M NaCl) containing 3% bovine serum albumin (Fraction V; Sigma) for blocking, incubated for 1 h at room temperature, and washed 3 times with Tris-buffered saline containing 0.1% Tween 20. The wells were supplemented successively with an anti-human IgG Fc antibody (Cappel, Aurora, OH) and a horseradish peroxidase-conjugated antigoat IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and then subjected to a colorimetric reaction using o-phenylenediamine. The amount of the reaction products was determined by measuring A 490 . We first conducted the reactions with no added proteins to determine background levels, which were almost negligible with any phospholipids. Binding of the Fc-fused proteins to plates either coated or not coated with phospholipids was then measured, the background value was subtracted from the differential between these two reactions, and the result was taken as the score of specific binding. Kinetic parameters for the binding of Fc-fused proteins to PS were determined using IAsys, an optical evanescence resonant mirror cuvette system, with the software FASTplot and Grafit (Affinity Sensors, Cambridge, UK). For examination of the binding of SR-BI to cells with externalized PS, Jurkat cells (1 ϫ 10 5 ) that had been treated with doxorubicin were incubated with the fusion protein containing a region corresponding to amino acid residues 33-191 (SRBI33-191-Fc) (numbered from the amino terminus) (0.55 mg/ml) or Axlecd-Fc (1.0 mg/ml) on ice for 30 min. The mixture was supplemented with a FITC-conjugated anti-human IgG antibody (Immunotech, Marseilles, France) and incubated on ice for another 30 min. The cells were then washed with phosphate-buffered saline containing 0.1% bovine serum albumin and examined under a fluorescence microscope.
Treatment with N-Glycanase-Protein samples were incubated with N-glycanase (Glyko, Novato, CA) at 37°C in a buffer containing 20 mM sodium phosphate (pH 7.5) and 50 mM EDTA (normal conditions). To obtain more complete digestion, the samples were pretreated with 0.3% SDS and 0.15 M 2-mercaptoethanol at 100°C for 3 min and incubated with the enzyme in the presence of 1.5% Nonidet P-40 (denaturing conditions). The samples treated with the enzyme were then analyzed by SDS-polyacrylamide gel electrophoresis followed by staining with Coomassie Brilliant Blue or Western blotting or by the PS binding assay.
Western Blotting-Protein samples including cells and culture media were solubilized in a buffer consisting of 0.0625 M Tris-HCl (pH 6.8), 2.5% SDS, and 2.5% 2-mercaptoethanol. Each sample was separated by 8% SDS-polyacrylamide gel electrophoresis, and proteins were electrophoretically transferred onto a polyvinylidene difluoride membrane. The membrane was blocked with 5% dry skim milk, incubated with either an anti-SR-BI antiserum or an anti-human IgG Fc antibody in Tris-buffered saline containing 0.1% Tween 20 and 5% dry skim milk, and washed. It was then reacted with an alkaline phosphatase-conjugated anti-rabbit antibody (Bio-Rad) or an alkaline phosphatase-conjugated anti-goat IgG antibody (Santa Cruz Biotechnology), and the signals were visualized using the Immun-Star system (Bio-Rad).
Microinjection and Terminal Deoxynucleotidyltransferase-mediated dUTP Nick End Labeling (TUNEL) Assay-Microinjection into the seminiferous tubules of live mice (ddY, 10 -15 weeks old) was carried out according to the method of Ogawa et al. (55) with modification (29) . Phosphate-buffered saline (50 -80 l) containing 2 mM CaCl 2 , 0.05% trypan blue, and SRBI33-191-Fc (16 or 25 M) was injected through the efferent duct. The microinjection was considered to be successful when more than half of the seminiferous tubules were stained blue. Testes were isolated after 0.5, 1, 3, and 7 days, immersed successively in phosphate-buffered saline containing paraformaldehyde and sucrose, and embedded with OCT compound (Sakura Finechemical, Tokyo, Japan) on dry ice/ethanol. The testes were then frozen-sectioned at 10-m thickness, treated with paraformaldehyde, then with ethanol/acetic acid. The sections were further treated with 3% hydrogen peroxide and subjected to the TUNEL assay using a commercial kit (ApopTag; Intergen, Purchase, NY). Signals were visualized by a coloring reaction with horseradish peroxidase and 3,3-diaminobenzidine tetrahydrochloride, and the samples were examined by microscopy after counterstaining with methyl green.
Antibodies-An anti-hamster SR-BI antiserum that had been raised against 45 amino acid residues located at the carboxyl terminus was kindly provided by H. Arai. To generate an anti-rat SR-BI antiserum, the synthetic peptide corresponding to amino acid residues 110 -132 of rat SR-BI (19, 56) with an extra Cys residue at the carboxyl terminus was coupled to keyhole limpet hemocyanin, emulsified with Freund's adjuvant, and injected into rabbits.
RESULTS

PS-mediated Binding of Rat SR-BI-expressing Cells to
Apoptotic Cells-In a previous study, we showed that Sertoli cellderived cell lines showed increased activity of both incorporating PS liposomes and phagocytosing apoptotic spermatogenic cells when they were transfected with rat SR-BI cDNA (19) . However, the interpretation of the results was rather complicated since those cell lines contained significant amounts of endogenous SR-BI. We therefore conducted similar experiments using CHO-K1 cells, which express only trace levels of SR-BI. Rat SR-BI cDNA was introduced into CHO-K1 cells, and three clones that expressed SR-BI protein at almost the same level were isolated; an example of the analysis of one of the clones is shown in Fig. 1A . These cell clones gave essentially the same results in subsequent experiments, and therefore, only results obtained with a representative clone are shown. When SR-BI-expressing CHO-K1 cells were mixed with apoptotic spermatogenic cells or Jurkat cells, efficient binding of the two cell types was observed (Fig. 1B) . However, in contrast to the results of our previous experiments with Sertoli-derived cell lines (19) , phagocytosis occurred only with reduced efficiency (data not shown). We therefore determined the extent of association of the two cell types without discriminating between binding and incorporation of target cells and expressed the results as "adhesion." The adhesion between SR-BI-expressing CHO-K1 cells and apoptotic Jurkat cells was specifically inhibited by liposomes containing PS (Fig. 1C) , and SR-BI-expressing CHO-K1 cells incorporated PS liposomes more effectively than the parent cells (Fig. 1D) . These results collectively indicate that ectopic expression of SR-BI endows cells with the ability to interact with PS-exposing apoptotic cells. The discrepancy between these and our previous observations indicates that CHO cells lack either intracellular molecules needed for transduction of the phagocytosis signal or surface receptors cooperating with SR-BI to induce engulfment.
Binding of Extracellular Domain of SR-BI to PS-We next examined whether SR-BI binds to PS in a more direct way. For this purpose, the extracellular region of rat SR-BI was expressed in a culture cell line as a fusion protein with the Fc region of human IgG (SRBIecd-Fc) and purified by protein A-Sepharose chromatography. The extracellular domain of the Gas6 receptor Axl was similarly obtained as a Fc-fusion protein (Axlecd-Fc). When proteins bound to and eluted from the resin were analyzed by SDS-polyacrylamide gel electrophoresis, both recombinant proteins appeared to be nearly homogeneous (lanes 1 and 2 in Fig. 2A ). As expected, SRBIecd-Fc reacted with both anti-Fc and anti-SR-BI antibodies, whereas Axlecd-Fc was detectable only with an anti-Fc antibody in Western blotting (lanes 3-6 in Fig. 2A) . These proteins were then examined for the activity of binding to PS in a cell-free solidphase assay. SRBIecd-Fc bound to plastic plates coated with PS, but not to PC-coated plates, in a dose-dependent manner, whereas Axlecd-Fc did not show affinity to either phospholipid (Fig. 2B) . Specific binding of SRBIecd-Fc to PS was also observed in an optical evanescence resonant mirror cuvette system, and the kinetics analysis revealed that SRBIecd-Fc bound to PS with a dissociation equilibrium constant of 2.4 ϫ 10 Ϫ7 M (Fig. 2C and Table I ). The presence of CaCl 2 was not essential for the binding of SRBIecd-Fc to PS, but it stimulated the activity (Fig. 2D) . The binding of SRBIecd-Fc to phospholipids seemed to be specific for PS; it did not bind to another aminophospholipid phosphatidylethanolamine or another anionic phospholipid phosphatidylinositol (Fig. 2E) .
We then conducted a structure-function analysis of SR-BI ( Fig. 3) . 293T cells were transfected with DNAs that coded for various portions of SRBIecd (top panel). However, only the fusion protein containing a region corresponding to amino acid residues 33-191 (SRBI33-191-Fc) was present in the culture medium (bottom panel). Other proteins also seemed to have been expressed in cells but did not undergo secretion into the medium (bottom panel). SRBI33-191-Fc was purified (Fig. 4A) and examined for PS binding activity. We found that the efficiency (Fig. 4B) and specificity (Fig. 4C) of the activity were indistinguishable between SRBI33-191-Fc and SRBIecd-Fc. In fact, the dissociation equilibrium constant of SRBI33-191-Fc for binding to PS, 3.6 ϫ 10 Ϫ7 M, which was determined in the analysis using IAsys (data not shown), was close to that of SRBIecd-Fc (Table I) . These results indicate that the region between amino acid residues 33 and 191 is responsible for the PS binding activity of rat SR-BI. 
N-Glycosylation of SR-BI and Its Effect on PS Binding Activity-Krieger
TABLE I Kinetic parameters for binding of SRBI-Fc proteins to PS
The kinetic constants were derived from the association and dissociation rates for the interaction of each protein with PS determined in IAsys using the FASTplot and Grafit kinetics analysis softwares. The data are from one experiment of two with similar results. k ass , association rate constant; k diss , dissociation rate constant; K D , dissociation equilibrium constant (k diss /k ass ). 
Phosphatidylserine Binding of SR-BI
goes N-glycosylation when it is expressed in CHO cells (57) . Because the mode of glycosylation varies depending on the cell type whether or not any proteins are glycosylated in any particular cell type needs to be examined directly. To test whether N-glycosylation of SR-BI occurred in Sertoli cells, lysates prepared from Sertoli cells of 20-day-old rats were denatured, incubated with N-glycanase, and analyzed by Western blotting. Treatment with the enzyme made the SR-BI signal more discrete and caused a significant reduction of the molecular mass (Fig. 5A ), indicating that SR-BI is N-glycosylated in Sertoli cells. The mobility of SRBIecd-Fc in a gel similarly increased after treatment with N-glycanase (Fig. 5B) . To determine the effect of N-glycosylation on the PS binding activity of SR-BI, we first tried to prepare SRBIecd-Fc with no N-glycosylation by maintaining the DNA-transfected 293T cells in the presence of tunicamycin. However, SRBIecd-Fc was not obtained from the culture medium; instead, it seemed to be retained within cells (Fig. 5C ). This indicates that modification by N-glycosylation is necessary for SRBIecd-Fc to be secreted. We therefore deglycosylated purified SRBIecd-Fc with N-glycanase and determined its activity. Because denaturation treatment caused loss of most activity (data not shown), the fusion protein was incubated with N-glycanase under the "normal conditions." This treatment results in partial deglycosylation of SRBIecd-Fc (see Fig. 5B ). To our surprise, the partially deglycosylated SRBIecd-Fc showed enhanced binding to PS (Fig. 5D) . (Fig. 6A) . Jurkat cells undergoing doxorubicin-induced apoptosis expressed PS at the cell surface and retained the integrity of the plasma membrane (data not shown). Apoptotic Jurkat cells incubated with SRBI33-191-Fc showed punctate cell surface staining in addition to dispersed faint fluorescence at the nucleus that was caused by DNA-bound doxorubicin. In contrast, Axlecd-Fc-treated cells gave only the nuclear staining, and normal Jurkat cells were not fluorescent even after incubation with SRBI33-191-Fc. These results indicate that SRBI33-191-Fc binds to PS present at the surface of apoptotic Jurkat cells. We then microinjected SRBI33-191-Fc into testes of live mice and histochemically analyzed the testes for changes in the number of apoptotic cells. Many TUNELpositive cells, which are rarely detectable in testes of normal mice (Refs. 29 and 58 and data not shown), were present in the SRBI33-191-Fc-injected testes, whereas injection of buffer alone did not show significant effects (Fig. 6B) . 5-10% of cross sections of the seminiferous tubules contained about 10 TUNEL-positive cells. The increase in the number of TUNELpositive cells was detectable in all 5 testes that were injected with SRBI33-191-Fc. The effect was most evident 1 day after injection and almost similar at two concentrations (16 and 25 M) of SRBI33-191-Fc (data not shown). Jurkat cells were not induced to undergo apoptosis when exposed to SRBI33-191-Fc at the same concentrations for 24 h (data not shown). These results resembled those obtained in our previous study, in which annexin V, another PS-binding protein, was injected into testes (29) . It can be speculated that SRBI33-191-Fc bound to the surface of apoptotic spermatogenic cells and protected them from being phagocytosed. The results from in vitro and in vivo experiments shown above indicate that SR-BI is responsible, at least in part, for phagocytosis of apoptotic spermatogenic cells by Sertoli cells.
Inhibition of Phagocytosis in Mouse Testes by SRBI33-191-Fc-We
DISCUSSION
In the present study, we showed that SR-BI binds to PS, the best-characterized phagocytosis marker. This is the first indication that a putative phagocytosis-inducing PS receptor directly binds to PS. The dissociation equilibrium constant (2.4 ϫ 10 Ϫ7 M), determined in a solid-phase binding assay, was small enough to support the specific interaction between SR-BI and PS. Henson and coworkers (59) recently report that the macrophage PS receptor is not involved in the physical interaction between macrophages and PS-exposing cells, but is absolutely required for the PS-dependent engulfment of those cells by macrophages. They have proposed the "tether and tickle" mechanism for phagocytosis of apoptotic cells in which they speculate that sets of ligands and receptors responsible for recognition/binding and engulfment are distinct (for review, see Refs. 60 and 61). However, our results indicate that a PS receptor in Sertoli cells, an amateur phagocyte present in the testis, plays a major role in the association between Sertoli cells and the target apoptotic spermatogenic cells. Therefore, the mode of action of PS receptors is unlikely to be uniform.
Besides behaving as a phagocytosis marker, PS serves as an activator of protein kinase C (for review, see Ref. 62 ), initiates blood coagulation, and seems to control the circulation of erythrocytes (63) . A number of proteins that are seemingly unrelated to phagocytosis have been shown to bind to PS; examples are protein kinase C (for review, see Refs. 62 and 64), protein kinase C substrate myristoylated alanine-rich C kinase substrate (65), coagulation factors V, VIIIa, and Xa, synaptic vesicle protein synaptotagmin I (66), vesicle-associated membrane protein-2 (67), seminal vesicle secretion protein SVS VII (68), erythrocyte protein 4.1R (69) , and annexin V (70) . Studies on the mode of PS binding of those proteins have revealed that protein kinase C (71), factor Xa (72), synaptotagmin I (66), and annexin V (73) require Ca 2ϩ either absolutely or preferably, and a distinct region called the C2 domain present in protein kinase C and synaptotagmin I is responsible for the Ca 2ϩ -dependent PS binding activity of the cognate proteins (74) . In addition, synthetic peptides that specifically bind to PS have been successfully obtained by using a monoclonal antibody recognizing PS (75) or a monoclonal anti-idiotypic antibody recognizing the PS-specific antibody (76) . However, full understanding of the structural basis for the interaction between PS and those proteins will require further investigation. The region spanning amino acid positions 33 and 191 was responsible for the PS binding activity of rat SR-BI. This region corresponds to the region of CD36, another member of the class B scavenger receptor family that includes domains responsible for the recognition of apoptotic neutrophils (77) and binding to oxidized low density lipoproteins (78) . The primary structure of this region, however, does not show similarity with those of the C2 domain of protein kinase C and related proteins, the ␥-carboxyglutamic acid domain of Gas6 (46), the motif FXFX-LKXXXKXR identified using an anti-idiotypic monoclonal antibody that recognizes a PS-recognizing monoclonal antibody (76) , or any other PS-binding proteins that have been reported so far. It is, thus, probable that there are multiple motifs defining the PS binding activity. Determination of the threedimensional structures of PS-binding proteins, as has been done with the C2 domain (71, 74, 79) and annexin V (80) , is necessary to determine the common structural basis for the PS-protein interaction if such a basis exists. Because the calcium ion appears to be directly involved in the interaction between the C2 domain and phospholipids (71, 81) , the modes of Ca 2ϩ -dependent and -independent binding of proteins to PS are expected to be different.
We showed that native SR-BI in rat Sertoli cells undergoes N-glycosylation. Recombinant SRBIecd-Fc expressed in human embryonic kidney cell line 293T was also N-glycosylated, and treatment of purified SRBIecd-Fc with N-glycanase brought about an increase in the level of the PS binding activity. Because the structure of N-linked sugar chains varies depending on the cell type, the above results do not necessarily mean that the modification by N-glycosylation is inhibitory for native SR-BI. However, they raise the possibility that the activity of SR-BI is regulated through changes in the level of N-glycosylation. Another member of the scavenger receptor family and a presumed PS receptor, LOX-1, is also N-glycosylated in bovine aortic endothelial cells (82) . The role of N-glycosylation in the function of LOX-1 is not clear either, but the modification seems to be required for cell-surface expression (82) . We obtained similar results here showing that treatment of 293T cells with tunicamycin inhibited the release of SRBIecd-Fc into the culture medium. In addition, several SR-BI-Fc fusion proteins, which lacked some of the presumed N-glycosylation sites, were not secreted into the culture medium even in the absence of tunicamycin. These results suggest that the N-glycosyl modification is required for the plasma membrane targeting of SR-BI.
The events lying downstream of the binding of PS to SR-BI are not clear at all. Inoue and coworkers (83) identify a protein that binds to the carboxyl terminus of SR-BI, but this protein does not seem to be involved in the transmission of phagocytosis signals from PS-bound SR-BI. Although the signaling pathway in Fc receptor-mediated phagocytosis has been extensively characterized (for review, see Refs. 84 -86) , the mechanism of induction of engulfment of apoptotic cells in general remains to be elucidated. The presence of two distinct signaling pathways has been predicted based on a genetic analysis with Caenorhabditis elegans (for review, see Refs. [87] [88] [89] . One pathway most likely involves the complex formation of signaling molecules CED-2, CED-5, and CED-10, but the receptor that presumably exists at the surface of phagocytes and recognizes phagocytosis markers in dying cells has yet to be identified. The mammalian counterpart of this unknown surface receptor is likely to be ␣ V ␤ 5 integrin, which recognizes phagocytosis markers other than PS (90) . The other pathway involves the membrane-integrated protein CED-1 (91) and the phosphotyrosine binding domain-containing protein CED-6 (92) . Because the presumed surface receptor in the former pathway is unlikely to bind to PS, CED-1 is anticipated to be the PS receptor in C. elegans. However, evidence supporting this expectation has not yet been obtained. Even more, whether cells dying in C. elegans undergo PS-dependent phagocytosis is uncertain. Further studies are needed to clarify how the binding of PS to SR-BI evokes engulfment of apoptotic cells. or phosphate-buffered saline alone, and the testis sections were subjected to the TUNEL assay after 1 day followed by examination by microscopy. Bars ϭ 50 m.
